NOS2 and musculoskeletal system disorder: Nrf2 signaling inhibits mediators like cyclooxygenase (COX-2) and inducible nitric oxide synthase (iNOS), which are critical for reducing inflammation and preventing conditions such as arthritis, epithelial neoplasms, and musculoskeletal disorders.